Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001292 · ClinicalTrials.gov registry record
Study of Scaling Disorders and Other Inherited Skin Diseases
A clinical trial of Lamellar Ichthyosis and Genetic Skin Disease, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1
- Study location
NCT00001292 is a study of Lamellar Ichthyosis and Genetic Skin Disease that has completed, run by National Cancer Institute (NCI). The trial reports 1 study location across 1 state.
The verdict
NCT00001292, a study of Lamellar Ichthyosis and Genetic Skin Disease, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1
- Study location
Study Summary
The purpose of this study is to identify the genes responsible for certain scaling disorders and other inherited skin diseases and to learn about the medical problems they cause. In some cases, these may include problems affecting organs other than the skin, such as the eyes, teeth and bones. Patients with inherited skin disorders, including Darier's disease (keratosis follicularis), lamellar ichthyosis, epidermolysis bullosa, cystic acne, and others, and their relatives may be eligible for this study. Patients will have a medical history, physical examination with particular emphasis on the skin, and routine blood tests. Additional procedures for patients and unaffected relatives may include: 1. Blood sample collection 2. Dental exam with X-ray of the jaw 3. Eye examination 4. X-rays of the skull, ribs, chest, hands, feet, spine, arms, or legs 5. Bone density scan 6. Photographs of the skin 7. Skin biopsies (removal of a small tissue sample under local anesthetic) 8. Buccal sample (gentle brushing inside the cheek to collect a cell sample) for gene studies Patients who request the results of their gene testing will be provided this information.
Conditions Studied
Study Locations (1)
Maryland
- National Cancer Institute (NCI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Start Date | 1992-02 |
| Est. Completion | 2001-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001292
The ClinicalTrials.gov registry entry for NCT00001292 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Lamellar Ichthyosis appearing as the primary indexed condition, and to 0 interventions.
NCT00001292 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001292 about?
NCT00001292 is a clinical study titled "Study of Scaling Disorders and Other Inherited Skin Diseases". The purpose of this study is to identify the genes responsible for certain scaling disorders and other inherited skin diseases and to learn about the medical problems they cause. In some cases, these may include problems affecting organs other than the skin, such as the eyes, teeth and bones. Patie...
What is the current status of trial NCT00001292?
This trial is currently completed. The study started on 1992-02. Estimated completion is 2001-04.
What conditions does trial NCT00001292 study?
This clinical trial studies the following conditions: Lamellar Ichthyosis, Genetic Skin Disease, Keratosis Follicularis.
Who is sponsoring clinical trial NCT00001292?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001292 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lamellar Ichthyosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.